Organogenesis Holdings Inc. - stock earnings

ORGO Quarterly earnings

DateEarningsRevenue
2023Q4 -568000 USD 99.7 million USD
2023Q3 12.1 million USD 108.5 million USD
2023Q2 5.3 million USD 117.3 million USD
2023Q1 -3.0 million USD 107.6 million USD
2022Q4 7.5 million USD 115.5 million USD
2022Q3 215000 USD 116.9 million USD
2022Q2 8.7 million USD 121.4 million USD
2022Q1 87000 USD 98.1 million USD
2021Q4 51.7 million USD 128.6 million USD
2021Q3 12.6 million USD 113.8 million USD
2021Q2 20.7 million USD 123.2 million USD
2021Q1 9.9 million USD 102.6 million USD
2020Q4 18.5 million USD 106.8 million USD
2020Q3 20.9 million USD 100.8 million USD
2020Q2 -5.2 million USD 69.0 million USD
2020Q1 -16.3 million USD 61.7 million USD
2019Q4 -4.4 million USD 74.6 million USD
2019Q3 -10.7 million USD 64.3 million USD
2019Q2 -9.6 million USD 64.9 million USD
2019Q1 -15.7 million USD 57.1 million USD
2018Q4 -9.3 million USD 63.6 million USD
2018Q3 4.9 million USD 50.8 million USD
2018Q2 356988 USD 39.5 million USD
2018Q1 -135653 USD 35.5 million USD
2017Q4 -498107 USD 6.6 million USD
2017Q3 -2.1 million USD 6.3 million USD
2017Q2 380334 USD ? USD
2017Q1 140863 USD ? USD
2016Q4 -178156 USD 61084 USD
2016Q3 -14492 USD ? USD
2016Q2 -500 USD ? USD
2016Q1 -15550 USD ? USD

ORGO Yearly earnings

DateEarningsRevenue
2023 4.9 million USD 433.1 million USD
2022 15.5 million USD 450.9 million USD
2021 94.2 million USD 468.1 million USD
2020 17.2 million USD 338.3 million USD
2019 -40.5 million USD 261.0 million USD
2018 -64.8 million USD 193.4 million USD
2017 -2.1 million USD 198.5 million USD
2016 -208698 USD ? USD
2015 -25160 USD 99.0 million USD
2001 -2.9 million USD 1.0 million USD

ORGO

Price: $2.42

52 week price:
1.80
4.71

Earnings Per Share: 0.04 USD

P/E Ratio: 33.30

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 317113

Market Capitalization: 380.1 million

Links: